-
NBIX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Neurocrine Biosciences (NBIX)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 241.00 mm | 241.00 mm | 241.00 mm | 241.00 mm | 241.00 mm | 241.00 mm |
Cash burn (monthly) | 38.70 mm | 1.51 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 78.22 mm | 3.05 mm | n/a | n/a | n/a | n/a |
Cash remaining | 162.78 mm | 237.95 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 4.2 | 157.8 | n/a | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 581 |
Opened positions | 108 |
Closed positions | 89 |
Increased positions | 208 |
Reduced positions | 204 |
13F shares | Current |
---|---|
Total value | 12.10 tn |
Total shares | 94.09 mm |
Total puts | 280.30 k |
Total calls | 281.30 k |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 14.78 mm | $2.02 tn |
Vanguard | 10.12 mm | $1.38 tn |
STT State Street | 4.89 mm | $667.65 bn |
Dodge & Cox | 3.02 mm | $411.74 bn |
Citadel Advisors | 2.54 mm | $346.45 bn |
Renaissance Technologies | 2.49 mm | $339.80 bn |
Aqr Capital Management | 1.90 mm | $258.93 bn |
Geode Capital Management | 1.88 mm | $255.52 bn |
BLVGF Bellevue | 1.82 mm | $248.43 bn |
MS Morgan Stanley | 1.57 mm | $214.76 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Feb 25 | Sherwin Stephen A | Common Stock | Sell | Dispose S | No | Yes | 116.6888 | 13,831 | 1.61 mm | 10,673 |
13 Feb 25 | Gorman Kevin Charles | Common Stock | Sell | Dispose S | No | Yes | 116.6832 | 3,012 | 351.45 k | 524,209 |
13 Feb 25 | Gorman Kevin Charles | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,603 | 0.00 | 527,221 |
13 Feb 25 | Gorman Kevin Charles | Common Stock | Sell | Dispose S | No | Yes | 116.6895 | 2,832 | 330.46 k | 521,618 |
13 Feb 25 | Gorman Kevin Charles | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,376 | 0.00 | 524,450 |
13 Feb 25 | Gorman Kevin Charles | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,603 | 0.00 | 16,812 |
13 Feb 25 | Gorman Kevin Charles | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,376 | 0.00 | 10,754 |
13 Feb 25 | Abernethy Matt | Common Stock | Sell | Dispose S | No | Yes | 116.8688 | 1,206 | 140.94 k | 35,810 |
13 Feb 25 | Abernethy Matt | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,241 | 0.00 | 37,016 |
13 Feb 25 | Abernethy Matt | Common Stock | Sell | Dispose S | No | Yes | 116.8487 | 1,352 | 157.98 k | 34,775 |